Biopharma M&A surges year over year in Q1

M&A dealmaking in the pharmaceutical and biotechnology industry is on the rise, signaling increased confidence and a focus on growth amid challenges. Read more here.

Related Keywords

Denmark ,Danish ,Alison Labya ,Ambrx Biopharma ,Novo Holding ,Fusion Pharmaceuticals ,Novo Nordisk ,Gilead Science ,Cymabay Therapeutics ,Data Business Fundamentals Analyst Alison Labya ,Inflation Reduction Act ,Biopharmaceutical Industry ,